5
Participants
Start Date
December 1, 2017
Primary Completion Date
March 1, 2024
Study Completion Date
March 1, 2024
CD3/CD19 neg allogeneic BMT
Negative selection for CD3/CD19 will be performed on a CliniMACS® depletion device within 36 hours of collection, and cryopreserved for later marrow transplantation. BMT conditioning and transplantation will start at least 8 weeks or more post lung transplant - once the participant is clinically judged suitable to undergo BMT conditioning and transplantion.
Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh
Collaborators (1)
University of Pittsburgh
OTHER
PPD Development, LP
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH